Nimotuzumab for EGFR-amplified Advanced Pan Solid Tumors
Clinical trial NCT06022276 · UNKNOWN
Trial details
- NCT number
- NCT06022276
- Sponsor
- Tianjin Medical University Second Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-01
- Primary completion
- 2024-12-31
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.